Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fieldwork Robotics agreement with Hall Hunter

6 Aug 2018 07:00

RNS Number : 8027W
Frontier IP Group plc
06 August 2018
 

RNS REACH / RNS

AIM: FIPP

6 August 2018

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Fieldwork Robotics collaboration agreement with leading soft-fruit grower Hall Hunter Partnership

 

 

Frontier IP, which specialises in commercialising university intellectual property, is pleased to announce portfolio company Fieldwork Robotics (the "Company") has entered into a collaboration agreement with leading UK soft-fruit grower Hall Hunter Partnership to prototype and field test a raspberry harvesting robot system.

 

The agreement with Hall Hunter Partnership, the country's biggest raspberry grower, is an important milestone for University of Plymouth spin-out Fieldwork Robotics in bringing its agricultural robot technology to market. Frontier IP owns 27.5 per cent of the Company.

 

Fieldwork's patent-pending technology consists of dedicated grippers, adaptable soft-robotic arms, sensors and software able to identify supermarket-ready fruit.

 

Proof of concept has been shown in laboratory conditions, but the collaboration will enable the Company to field test and further refine the technology by working in a range of environments, such as fields and polytunnels, under different climatic and light conditions. Field tests are expected to start later this year.

 

Once the technology has been successfully tested with raspberries, among the softest and most easily damaged fruit to pick, then it can be easily adapted to other fruit and vegetables. The Company is developing proof-of-concept robots for other crops following interest from leading agribusinesses.

 

The academic behind the technology, Dr Martin Stoelen, Lecturer in Robotics at the University of Plymouth, is working on a tomato harvesting project with the Shanghai Jiaotong University in China. The University of Plymouth has also received grants to develop applications for cauliflowers and other vegetables.

 

Hall Hunter Partnership grows 14,000 tonnes of raspberries, strawberries, blackberries and blueberries. Its major customers include Waitrose, Marks & Spencer and Tesco. The family-run business owns farms and glass houses in Berkshire, Surrey and West Sussex in the UK and, to produce year-round, also runs a farm in Portugal.

 

Fieldwork Robotics has been incorporated to develop and commercialise the work of Dr Stoelen and his team at the University of Plymouth.

 

Hall Hunter Partnership chief operating officer David Green said: "HHP has always led the soft fruit industry in pushing forward productivity and quality standards on our Farms and Nurseries. This partnership with Fieldwork Robotics is an exciting new development to pioneer the harvesting of raspberries robotically at a commercial scale. We are looking forward to our first human-free hectare to be picked together "

 

Frontier IP chief executive Neil Crabb said: "Working with industry partners is absolutely vital to ensuring university IP is developed in a way that meets real-world needs and can be scaled up properly. We're delighted to collaborate with one of the UK's leading soft-fruit growers to take Fieldwork Robotics' technology through the next stage of its development."

 

Fieldwork Robotics founder and director Dr Martin Stoelen said: "The collaboration agreement we've signed with Hall Hunter is a big step forward for Fieldwork and the team at the University of Plymouth. I'm looking forward to seeing our robots operating in the field. "

 

 

 

ENQUIRIES

Frontier IP Group Plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

andrew.johnson@frontierip.co.uk

Company website: www.frontierip.co.uk

 

M: 07464 546 025

Cenkos Securities plc (Nominated Adviser and Joint Broker)

T: 0131 220 6939

Neil McDonald / Beth McKiernan

 

Peterhouse Corporate Finance Limited (Joint Broker)

T: 020 7469 0935

Lucy Williams

 

Kreab (Financial PR)

T: 020 7074 1800

Robert Speed / Matthew Jervois

NOTES TO EDITORS

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services.

The Group looks to build and grow a portfolio of equity stakes and licence income from by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAFKNDBDBKDQFK
Date   Source Headline
7th May 202410:15 amRNSTVG to collaborate with The Pirbright Institute
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.